Table 2.
Utilization of praziquantel among patients with schistosomiasis diagnoses, 2013–19
| Characteristic | Adjusted odds ratio (95% CI) | P value |
|---|---|---|
| Gender | ||
| Female | Reference | – |
| Male | 1.31 (0.83–2.08) | 0.24 |
| Age | ||
| ≤ 40 years old | Reference | – |
| > 40 years old | 0.69 (0.44–1.09) | 0.12 |
| Living area | ||
| Urban | Reference | – |
| Rural | 0.18 (0.04–0.80) | 0.02 |
| No. of outpatient-visit days | ||
| 1 day | Reference | – |
| ≥ 2 days | 4.10 (2.58–6.51) | < 0.01 |
| Insurance type | ||
| Non-capitated | Reference | – |
| Capitated | 0.69 (0.33–1.48) | 0.34 |
| Species of schistosome* | ||
| Others (specified and unspecified) | Reference | – |
| S. haematobium | 0.43 (0.23–0.82) | 0.01 |
| S. mansoni | 0.77 (0.40–1.51) | 0.45 |
| Period | ||
| 2013–14 | Reference | – |
| 2015–16 | 0.52 (0.29–0.93) | 0.03 |
| 2017–19 | 1.03 (0.60–1.76) | 0.92 |
*
Schistosoma haematobium included International Classification of Diseases, 9th Edition, Clinical Modification (ICD-9-CM) code 120.0 and ICD-10-CM code B65.0. Schistosoma mansoni included ICD-9-CM code 120.1 and ICD-10-CM code B65.1. Others included ICD-9-CM codes 120.8 (other specified schistosomiasis) and 120.9 (schistosomiasis, unspecified), and ICD-10-CM codes B65.8 (other schistosomiasis) and B65.9 (schistosomiasis, unspecified).